Abstract
A simple and efficient synthesis of nAChR antagonist (±)-7-methyl-2-exo-(3′-iodo-5′-pyridinyl)-7-azabicyclo[2.2.1]-heptane ((±)-NMI-EPB) has been developed. Both enantiomers of (±)-NMI-EPB were separated by semi-preparative chiral HPLC. The enantiomers manifested a substantial difference in their inhibition binding affinities ((+)-NMI-EPB, Ki = 2310, 1680 pM; (-)-NMI-EPB, Ki = 55, 68 pM). The enantiomers were stereoselectively radiolabeled with 11C. In the distribution studies in the rodent brain [11C](-)-NMI-EPB specifically labeled nAChR whereas [11C](+)-NMI-EPB exhibited little specific binding. In the baboon PET study [11C](-)-NMI-EPB did not reach steady-state within 90 min post-injection suggesting that the radioligand may have some limitations for quantitative imaging.
Original language | English |
---|---|
Pages (from-to) | 6168-6170 |
Number of pages | 3 |
Journal | Bioorganic and Medicinal Chemistry Letters |
Volume | 18 |
Issue number | 23 |
DOIs | |
State | Published - Dec 1 2008 |
Keywords
- C-11
- Enantiomers
- Positron emission tomography (PET)
- nAChR